Navigation Links
MO BIO Laboratories, Inc. launches new kits for fast DNA and RNA clean-up
Date:11/19/2013

CARLSBAD, Calif., Nov. 19, 2013 /PRNewswire/ -- MO BIO Laboratories, Inc., the leader in microbial, stool, plant, and soil nucleic acid purification, announces the launch of the PowerClean® Pro DNA and RNA Clean-Up Kits, featuring a fast, 7 minute protocol for removal of amplification inhibitors including humic substances, polysaccharides, polyphenolics, heme, and lipids from purified DNA or RNA.

(Photo: http://photos.prnewswire.com/prnh/20131119/LA19528)

The PowerClean® Pro DNA and RNA Clean-Up Kits are the latest products in MO BIO's Power line of kits which contain patented Inhibitor Removal Technology® (IRT). IRT eliminates inhibitory substances often contained in soil, water, stool, plants, seeds, biofilm and other sample types, resulting in pure nucleic acids that are ready to use in PCR, qPCR and next generation sequencing

Features of the PowerClean® Pro DNA and RNA Clean-Up Kits include:

  • Efficient secondary purification – Fast and easy 7 minute protocol to clean up your problematic DNA or RNA
  • Removes challenging impurities – Purifies nucleic acids containing humic substances, polyphenolics, polysaccharides and other amplification inhibitors
  • Successful amplification - High purity nucleic acids for use in PCR, qPCR and next generation sequencing

The PowerClean® Pro DNA and RNA Clean-Up Kits are available now. For more information, visit the MO BIO website (http://mobio.com/powerclean-pro) or call 800-606-6246.

MO BIO Laboratories, Inc. (www.mobio.com) has developed innovative tools for researchers in molecular biology since 1993. A global leader in solutions for soil and microbial nucleic acid purification, MO BIO's Power kits contain patented Inhibitor Removal Technology® for removal of PCR inhibiting substances during the nucleic acid purification procedure. For clinical samples, the BiOstic™ kits provide solutions for higher yields and purity of nucleic acids. At MO BIO Laboratories, Inc., our focus is quality products that work, save time and function for all sample types, not just the easy ones. It is MO BIO's aim to make researchers' working lives more productive and efficient, creating time to focus on what is critical, not just in work, but in life.


'/>"/>
SOURCE MO BIO Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. IGI Laboratories, Inc. Announces Thirteenth ANDA Submission
2. IGI Laboratories, Inc. Receives Formal US FDA Approval For Site Transfer Of Econazole Nitrate
3. IGI Laboratories, Inc. Announces Twelfth ANDA Submission
4. MO BIO Laboratories, Inc. launches a new kit for isolation of viral nucleic acids from environmental samples
5. Global Vascular Stents Market 2012-2016 Report with Abbott Laboratories, Medtronic Inc. and Boston Scientific Corp. Dominating
6. Charleston Laboratories, Inc. Announces Successful Completion of Pre-IND Meeting on New Migraine Treatment CL-H1T
7. Clontech Laboratories, Inc. Partners With Rubicon Genomics To Increase Speed And Efficiency Of Sample Preparation For RNA Sequencing
8. Besins Healthcare, Shin Nippon Biomedical Laboratories, Ltd Announce Delivery Technology Licensing Agreement for Intranasal Progesterone
9. FDA Grants Charleston Laboratories, Inc. Request for Pre-IND Meeting on New Migraine Treatment
10. Antigen Laboratories, Inc. to be Acquired by Ares Life Sciences
11. Positive Data, Pipeline Improvements & Market Expansion - Research Report on Abbott Laboratories, Stryker Corporation, St. Jude Medical, Cardiovascular Systems and MAKO Surgical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... IBM ) Research has today announced new research developments ... retina. The Melbourne based IBM researchers ... in retina images, which could in the future offer doctors ... who may be at risk of eye diseases – such ... world. The research began in 2015 and ...
(Date:2/21/2017)... 21, 2017  Luminex Corporation (NASDAQ: LMNX ) ... authorized the initiation of a quarterly cash dividend to its ... dividend will be payable on April 14, 2017 to shareholders ... 24, 2017. The board of directors intends ... of $0.06 to holders of its common stock, representing a ...
(Date:2/21/2017)... NEW YORK , Feb. 21, 2017 /PRNewswire/ ... healthcare industry. This technique is allowing a previously ... and simplicity. Due to this ability, it is ... will cross US$ 4 Billion by 2022. The ... driven by advancements in computing platforms, rising installation ...
Breaking Medicine Technology:
(Date:2/21/2017)... ... February 21, 2017 , ... Hanna Boys ... at PolicyLink, will be the keynote speaker at its second Professional Networking Breakfast ... Color Framework, which develops comprehensive strategies to create and expand opportunities for boys ...
(Date:2/21/2017)... ... February 21, 2017 , ... Individuals ... problems directly related to surgery, treatment, therapy and management. Regular exercise in proper ... qualities of life despite their diseases. On February 23, 2017, 1:00-2:00 p.m. E.S.T., ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... coverage in veterinary medicine, will be launching its first bi-monthly issue of 2017 ... medicine, business and practice management, and One Health. , In making the ...
(Date:2/21/2017)... ... February 21, 2017 , ... Atlanta-based ... predictive analytic firm Predixion’s Healthcare IT practice. Predixion, which raised $42M+ to date, ... by giants including Accenture, GE Ventures, and Software AG , will bring ...
(Date:2/21/2017)... ... February 21, 2017 , ... A February 6 article on Healio ... It found that the treatments have led to significant improvements in weight loss and ... efforts. It also noted very few problematic results relating to the treatment. Beverly Hills ...
Breaking Medicine News(10 mins):